Professor Raymond Tallis gives a talk based on his best-selling "NHS SOS - how the NHS was betrayed and how we can save it." Talk hosted by Stockport NHS Watch and Keep Our NHS Public.
Performance poet Rachel Amey looks over the border from Scotland and delivers a searing account of the attack on the English NHS. Performance recorded at the Bongo Club in Edinburgh.
We have just seen the importance of democracy in relation to matters of life and death overseas. We must restore it at home, too.
The government is giving away the rights to up to a billion tonnes of coal to a company owned by an ex-Conservative party fundraiser. Rather than filling his pockets, couldn't this revenue source be used for the public good?
As large charities succumb to market ideology, the fate of genuinely independent grassroots organisations - such as those supporting midwives and new mothers - hangs in the balance.
Labour has a chance to show it’s serious about saving the NHS from death by a thousand privatisations.
The tragedy of privatisation in England is that it is controlled by that of Britain. Those reactionaries who then focus on the issues with Britain are diluting their cause; we need to concentrate our energies and campaigns in one direction – that of England and England alone.
Any extra A&E cash is welcome - but Cameron is still putting private providers and investors before patients.
The NHS is paying millions to a failed private Treatment Centre to escape a contract after a series of patient deaths - and the figures don't quite add up.
The results have been terrible. Soaring prices, corruption, fraud, enormous expense to the public purse. But Westminster is determined to keep on privatising. New campaign, 'We Own It', says enough is enough.
After this week's "Failed by the NHS" documentary, Ramona asks, can we criticise the shortcomings of NHS mental health care whilst arguing against NHS privatisation?
Serco was pleased to announce last week that GSTS Pathology – its joint venture with two London hospitals - was back in profit. But newly-released accounts show that, even after lab closures and accusations of cutting corners, GSTS is not yet the success story its owners like to suggest.
